Arvinas, Inc. (ARVN): Depreciation & Amortization
$3.00M
Year ended 2025-12-31
$2.90M
Trailing 12 months to 2026-06-30
-21.9%
3-year compound annual growth
-1.3%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.00M | -34.8% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $4.60M | -4.2% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $4.80M | -23.8% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $6.30M | +31.3% | 2025-02-11, From 2022-01-01 |
| 2021-12-31 | $4.80M | +50.0% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $3.20M | +100.0% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $1.60M | n/c | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $706.0K | +103.2% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $347.4K | n/a | 2019-03-26, From 2017-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Arvinas, Inc. (ARVN) | 2025-12-31 | $3.00M | -34.8% |
| Ligand Pharmaceuticals Inc (LGND) | 2025-12-31 | $33.77M | -4.2% |
| Vireo Growth Inc. (VREOF) | 2025-12-31 | $16.11M | +535.0% |
| Schrodinger, Inc. (SDGR) | 2025-12-31 | $6.02M | -2.2% |
| Harrow, Inc. (HROW) | 2025-12-31 | $1.92M | +3.5% |
| Arcus Biosciences, Inc. (RCUS) | 2025-12-31 | $10.00M | 0.0% |
| Xeris Biopharma Holdings, Inc. (XERS) | 2025-12-31 | $1.31M | +7.0% |
| Anaptysbio, Inc (ANAB) | 2025-12-31 | $559.0K | -7.8% |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $1.10M | -8.3% |
Compare ARVN, LGND, VREOF, SDGR side by side · Screen every company in Pharmaceutical Preparations ↗